New founder germline mutations ofCDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment-Reference-Cited by-同舟云学术

New founder germline mutations ofCDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment

Published:2007 Issue:8 Volume:46 Page:751-760
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Kannengiesser Caroline,Dalle Stéphane,Leccia Marie-Thérèse,Avril Marie Françoise,Bonadona Valerie,Chompret Agnès,Lasset Christine,Leroux Dominique,Thomas Luc,Lesueur Fabienne,Lenoir Gilbert,Sarasin Alain,Bressac-de Paillerets Brigitte

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference53 articles.

1. Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway

2. . 1996. Cutaneous malignant melanoma. In: , editors. Cancer Epidemiology and Prevention. New York: Oxford University Press, p. 1312.

3. Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

4. Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanin—The Éminence Grise of Melanoma and Parkinson’s Disease Development;Cancers;2023-11-23

2. CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition;Hereditary Cancer in Clinical Practice;2021-03-25

3. The evolution of Sex-linked barring alleles in chickens involves both regulatory and coding changes in CDKN2A;PLOS Genetics;2017-04-07

4. Cutaneous malignant melanoma and Parkinson disease: Common pathways?;Annals of Neurology;2016-11-14

5. Sex-linked barring in chickens is controlled by the CDKN2A /B tumour suppressor locus;Pigment Cell & Melanoma Research;2010-03-29